EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”

Hui-Ling Huang, Sheng-Nan Lu

Biomedical Journal · 2026-12 · 49 (6) · 101015

DOI: 10.1016/j.bj.2026.101015 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Biomedical Journal, 2026-12. Verfasst von Hui-Ling Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Chang Gung Memorial Hospital, Chiayi, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Nursing, Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • Department of Hepato-Gastroenterology, Division of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Electronic address: juten@ms17.hinet.net.

Zitieren

APA

Huang, H. L., & Lu, S. N. (2026). Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. Biomedical Journal, 49(6), 101015. https://doi.org/10.1016/j.bj.2026.101015

Vancouver

Huang HL, Lu SN. Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. Biomedical Journal. 2026;49(6):101015. doi:10.1016/j.bj.2026.101015

BibTeX
@article{Huang2026,
  author = {Huang, Hui-Ling and Lu, Sheng-Nan},
  title = {Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”},
  journal = {Biomedical Journal},
  year = {2026},
  volume = {49},
  number = {6},
  pages = {101015},
  doi = {10.1016/j.bj.2026.101015}
}
Kostenlos starten →